Many medical “rainy day” accounts aren’t getting opened or filled, study finds

People with high-deductible health plans aren’t using health savings account option as intended
Michigan Medicine - University of Michigan

Newswise — One-third of the people who could benefit from a special type of savings account to cushion the blow of their health plan deductible aren’t doing so, according to a new study.

And even among people who do open a health savings account (HSA), half haven’t put any money into it in the past year. This means they may be missing a chance to avoid taxes on money that they can use to pay for their health insurance deductible and other health costs.

The study also finds that those who buy their health insurance themselves, and select a high-deductible plan on an exchange such as www.healthcare.gov, are less likely to open an HSA than those who get their insurance from employers who offer only a high-deductible option.

HSAs are different from the flexible spending accounts that some employers offer. HSAs can only be opened by people in health plans that require them to pay a deductible of $1,400 for an individual or $2,800 for a family before their insurance benefits kick in.

In a new paper in JAMA Network Open, a team led by researchers at the University of Michigan and VA Ann Arbor Healthcare System reports results from a national survey of more than 1,600 participants in high-deductible health plans.

Key findings

They note that half of those who had an HSA and put money into their account in the past year had socked away $2,000 or more. And among those who hadn’t put money in, 40% said it was because they already had enough savings to cover their costs.

But those with lower levels of education were much less likely to have opened an HSA, and to have contributed to it even if they did open one. Those with lower levels of understanding of health insurance concepts, called health insurance literacy, were also less likely to put money in their HSA if they had one.

And one-third of those who didn’t put money into their HSA said it was because they couldn’t afford to save up for health costs.

“These findings are concerning, given that nearly half of Americans with private insurance now have high-deductible plans,” says Jeffrey Kullgren, M.D., M.S., MPH, who led the study and has done other research on HDHPs and health care consumerism. “While policymakers have focused on expanding availability and permitted uses of HSAs, and increasing how much money they can hold, work is needed to help eligible enrollees open them and use them to get the care they need at a price they can afford.”

Change needed

In the new paper and in a report from the U-M Institute for Healthcare Policy and Innovation, Kullgren and his colleagues call for more efforts to increase uptake of HSAs, and contributions to HSAs, by employers, health insurers and the health systems that provide care and bill insurers for that care. Targeted interventions, especially those aimed at people with lower levels of education or health insurance literacy, should be developed.

The researchers note that as federal and state exchanges prepare to open for 2021 enrollment, expanding the types of exchange plans that are eligible to be linked to an HSA will be important. Currently, just 7% of the plans bought on exchanges are eligible for an HSA, even though many exchange plans come with a high deductible.

The study data come from an online survey of English-speaking adults under age 65; the study population was weighted to include a higher proportion of people with chronic health conditions than the national population.

For the survey, the researchers asked respondents about HSAs using the National Health Interview Survey definition of an HSA as “a special account or fund that can be used to pay for medical expenses” that are “sometimes referred to as Health Savings Accounts (HSAs), Health Reimbursement Accounts (HRAs), Personal Care accounts, Personal Medical funds, or Choice funds, and are different from Flexible Spending Accounts.”

In addition to Kullgren, who is an assistant professor of internal medicine at the U-M Medical School and member of IHPI and the VA Center for Clinical Management Research, the study team includes U-M School of Public Health doctoral alumna Elizabeth Q. Cliff, PhD; U-M research team members Christopher Krenz, BA; Brady T. West, PhD; Helen Levy, PhD, and Mark Fendrick, MD; and Angela Fagerlin, PhD of the University of Utah and Salt Lake City VA. The study was funded by the Robert Wood Johnson Foundation and the Department of Veterans Affairs. Fendrick is a partner in V-BID Health, LLC, which assists employers, health insurers and health systems in designing health care benefits packages.  The research was funded by the Robert Wood Johnson Foundation and the Veterans Health Administration.

SEE ORIGINAL STUDY




Filters close

Showing results

110 of 3321
Newswise: 243389_web.jpg
Released: 18-Sep-2020 10:55 AM EDT
Potential new drug to mitigate SARS-CoV-2 infection consequences
University of Malaga

Scientists from the Department of Cell Biology of the University of Malaga (UMA) and the Andalusian Centre for Nanomedicine and Biotechnology (BIONAND) have made progress in finding new rapid implementation therapies to combat the COVID-19 pandemic, identifying a new drug that could prevent or mitigate the consequences derived from SARS-CoV-2 infection.

Newswise: 243400_web.jpg
Released: 18-Sep-2020 10:40 AM EDT
Most homemade masks are doing a great job, even when we sneeze, study finds
University of Illinois at Urbana-Champaign

Studies indicate that homemade masks help combat the spread of viruses like COVID-19 when combined with frequent hand-washing and physical distancing.

access_time Embargo lifts in 2 days
Embargo will expire: 23-Sep-2020 8:00 AM EDT Released to reporters: 18-Sep-2020 10:00 AM EDT

A reporter's PressPass is required to access this story until the embargo expires on 23-Sep-2020 8:00 AM EDT The Newswise PressPass gives verified journalists access to embargoed stories. Please log in to complete a presspass application. If you have not yet registered, please Register. When you fill out the registration form, please identify yourself as a reporter in order to advance to the presspass application form.

Released: 18-Sep-2020 8:30 AM EDT
Immunotherapy Drug Development Pipeline Continues Significant Growth in 2020 Despite Global Pandemic Impact
Cancer Research Institute

Despite the impact of the COVID-19 pandemic across the globe, there has been a resurgence of interest in immuno-oncology (I-O) preclinical and clinical development, bringing hope to cancer patients and physicians who treat them.

Released: 17-Sep-2020 5:50 PM EDT
AERA and OECD to Co-Host Webinar on Education Research Worldwide in a Covid and Post-Covid World
American Educational Research Association (AERA)

The American Educational Research Association (AERA) and the Organisation for Economic Co-operation and Development (OECD) will co-host a webinar on “Education Research Worldwide in a Covid and Post-Covid World” at 9:30-11:00 am EDT Wednesday, September 23.

Newswise: 243232_web.jpg
Released: 17-Sep-2020 4:20 PM EDT
Study shows first proof that a safer UV light effectively kills virus causing COVID-19
Hiroshima University

A study conducted by Hiroshima University researchers found that using Ultraviolet C light with a wavelength of 222 nanometers which is safer to use around humans effectively kills SARS-CoV-2 -- the first research in the world to prove its efficacy against the virus that causes COVID-19.

Newswise:Video Embedded american-academy-of-dermatology-honors-detroit-physician-iltefat-h-hamzavi-with-national-patient-care-hero-award
VIDEO
Released: 17-Sep-2020 4:00 PM EDT
American Academy of Dermatology honors Detroit physician Iltefat H. Hamzavi with national “Patient Care Hero” award
American Academy of Dermatology

The American Academy of Dermatology has named board-certified dermatologist Iltefat H. Hamzavi, MD, FAAD, a Patient Care Hero for his innovative use of light therapy to sanitize masks needed by frontline health care workers.

access_time Embargo lifts in 2 days
Embargo will expire: 22-Sep-2020 11:00 AM EDT Released to reporters: 17-Sep-2020 3:20 PM EDT

A reporter's PressPass is required to access this story until the embargo expires on 22-Sep-2020 11:00 AM EDT The Newswise PressPass gives verified journalists access to embargoed stories. Please log in to complete a presspass application. If you have not yet registered, please Register. When you fill out the registration form, please identify yourself as a reporter in order to advance to the presspass application form.

Released: 17-Sep-2020 3:05 PM EDT
Does a New Study Give Evidence that the Coronavirus Was Made In a Lab?
Newswise

Scientists in a new paper make strong claims regarding evidence that the COVID-19 virus did not originate in nature—the prevailing theory—but instead was made in a lab. According to six leading experts in evolutionary biology and infectious disease consulted by Newsweek, the paper offers no new information, makes numerous unsubstantiated claims and its scientific case is weak.


Showing results

110 of 3321

close
1.7988